Pensioner left without medication after demand surge for slimming jabs
페이지 정보
본문
A 79-year-old man has been forced to go without his diabetes medication after supplies were snapped up by people desperate to lose weight.
John Noble, who lives in Livingston, was prescribed semaglutide, branded as Ozempic, two years ago to control his type 2 diabetes.
But his GP has now told him that he will not receive his prescription until 2024 due to a spike in demand for the once-weekly jab.
Ozempic helps manage blood sugar levels in diabetes patients. But it has also been hailed as a 'miracle' weight-loss drug by celebrities including Elon Musk and Jeremy Clarkson, which has triggered a clamour to get hold of it.
As a result, global supplies of semaglutide have been running low, leading health chiefs to warn that diabetes patients' lives are at risk.
Mr Noble has said he will now struggle to manage his diabetes without the drug and "http://bramptoneast.org/index.php/Kupi_Reduslim_Za_Naravno_Huj%C5%A1anje faces a £75-a-week fee if he goes private.
John Noble was taking a drug called Ozempic through the NHS to control his type 2 diabetes but has been told he may have to go without until next year due to soaring demand
Demand for Ozempic, which contains the same active ingredient, semaglutide, as the weight loss jab Wegovy has surged, causing a global shortage
Ozempic is available on the NHS as a treatment for managing blood glucose levels in people with type 2 diabetes.
In May, semaglutide was also approved for weight loss under the brand name Wegovy.
However, it was not until this week that the NHS and private clinics received a restricted number of doses of Wegovy.
The delay has led to a rise in 'off-label' prescribing of Ozempic — where medications are issued for something other than its intended use — which is exacerbating global shortages of both drugs.
Mr Noble was told by his GP that semaglutide's recent burst in popularity means he won't be able to get any until next year at the earliest.
John Noble, who lives in Livingston, was prescribed semaglutide, branded as Ozempic, two years ago to control his type 2 diabetes.
But his GP has now told him that he will not receive his prescription until 2024 due to a spike in demand for the once-weekly jab.
Ozempic helps manage blood sugar levels in diabetes patients. But it has also been hailed as a 'miracle' weight-loss drug by celebrities including Elon Musk and Jeremy Clarkson, which has triggered a clamour to get hold of it.
As a result, global supplies of semaglutide have been running low, leading health chiefs to warn that diabetes patients' lives are at risk.
Mr Noble has said he will now struggle to manage his diabetes without the drug and "http://bramptoneast.org/index.php/Kupi_Reduslim_Za_Naravno_Huj%C5%A1anje faces a £75-a-week fee if he goes private.
John Noble was taking a drug called Ozempic through the NHS to control his type 2 diabetes but has been told he may have to go without until next year due to soaring demand
Demand for Ozempic, which contains the same active ingredient, semaglutide, as the weight loss jab Wegovy has surged, causing a global shortage
Ozempic is available on the NHS as a treatment for managing blood glucose levels in people with type 2 diabetes.
In May, semaglutide was also approved for weight loss under the brand name Wegovy.
However, it was not until this week that the NHS and private clinics received a restricted number of doses of Wegovy.
The delay has led to a rise in 'off-label' prescribing of Ozempic — where medications are issued for something other than its intended use — which is exacerbating global shortages of both drugs.
Mr Noble was told by his GP that semaglutide's recent burst in popularity means he won't be able to get any until next year at the earliest.
- 이전글UPDATE 4-Philip Morris in talks to buy smaller rival Swedish Match 23.09.16
- 다음글reduslim cena - 16914142151 23.08.30
댓글목록
등록된 댓글이 없습니다.